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ABSTRACT         24 
 25 
Background and Purpose: Breast cancer treatments may cause late effects of pain, range of 26 
motion loss, and activity limitation in the upper extremity (UE). The purpose of this case report 27 
was to describe the utilization of soft tissue techniques with instrument assisted soft tissue 28 
mobilization (IASTM) in outpatient physical therapy to address decreased UE function and pain 29 
for a patient post-surgery, chemotherapy, endocrine therapy and radiation.   30 
Case Description: The patient was a 61-year-old female referred to physical therapy (PT) for 31 
restricted mobility and pain in her right UE post-oncologic treatments preventing her from 32 
vocation and participating in daily activities. The initial evaluation demonstrated right UE 33 
weakness of 4/5 (withstand light resistance), painful right active end-range of motion pulling 34 
into the hip and trunk with corresponding right-sided tissue puckering and mottling. The patient 35 
received 26 visits over 23 weeks combining manual therapy techniques, IASTM, yoga, a foam 36 
rolling program, and therapeutic exercises.  37 
Outcomes: At the recertification at week 23, she demonstrated outcome measure improvements 38 
in right UE strength 4/5 to 4+5 (withstand moderate resistance); increased tolerance of UE end-39 
range AROM with decreased reported pain sensation; Quick Disability of the Shoulder Arm and 40 
Hand score decrease (27.27/100 to 11.36/100); Numeric Pain Rating Scale decrease (2/10 to 41 
1/10); and Pain Disability Index decrease (2/10 to 1/10). 42 
Discussion: The prescribed treatment plan appeared to be beneficial for this patient. Orthopedic 43 
outpatient PT rehabilitation for UE conditions in breast cancer survivors should have 44 
consideration to effects of surgical, medical and radiation treatments both locally and 45 
systemically. The pursuit of therapists’ continuing education for future treatment considerations 46 
of breast cancer survivors post-surgery combined with endocrine, chemotherapy and radiation 47 
may enhance efficacy of soft tissue mobilization and therapeutic exercises.  48 
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  50 
INTRODUCTION/BACKGROUND and PURPOSE  51 
Breast cancer is an abnormal growth (carcinoma) originating in breast tissue. Malignant 52 
breast tumors, or lesions, have the potential to spread to other areas of the body, or metastasize.1 53 
Breast cancer is defined pathologically by location of origin in the breast (e.g. ducts, lobes), size 54 
of the tumor, status of the nodes, and the presence of markers indicating tumor staging.1 55 
Carcinoma is pathologically staged from 0-IV based on that assessment, (stage 0 indicates 56 
carcinoma in situ and stage IV indicates late or metastatic disease).1 Following biopsy, the 57 
presence of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth 58 
factor (HER) give prognostic information about the carcinoma.1 Breast cancer is the second most 59 
common form of carcinoma found in women in the United States following skin cancers.1 In 60 
2020, an estimated 276,480 women were diagnosed with breast cancer in the United States, and 61 
it accounted for 42,170 deaths.2  Due to advances in early detection and adjuvant treatment (post-62 
surgical chemotherapy/radiation/endocrine therapy) the incidence and mortality rates of breast 63 
cancer appear to be declining in the United States.1 Treatment has evolved in various surgical 64 
techniques, adjuvant chemotherapy, pre-surgical chemotherapy (neoadjuvant), immunotherapy, 65 
radiation therapy (RT) and endocrine therapies (ET).1,3  66 
Although treatment techniques have been found to be effective in decreasing the 67 
recurrence of breast carcinoma, the body may exhibit late effects including decreased mobility, 68 
strength and quality of life.3,4 Not only are these impairments in the affected upper extremity 69 
(UE) caused by surgical procedures like axillary lymph node dissection (ALND), but these 70 
therapies significantly increase the risk of developing lymphedema (inability to remove 71 
accumulation of excess fluid from an area) and/or axillary cording (scarring or adhesion of 72 





connective tissue under the skin).5,6,7 In many patients following surgery, chemotherapy, and RT, 73 
limitations in returning to work, activities of daily life (ADL), and social activities are present 74 
due to pain and range of motion (ROM) decline in the UE.3,4,5 75 
The rationale for this case report was to illustrate the importance of the management of a 76 
61-year-old female patient following mastectomy, with emphasis on the local and systemic 77 
results of RT, ET and chemotherapy indicating a multifaceted approach physical therapist (PTs) 78 
must take in treatment. There are few specific manual therapy techniques or parameters for ROM 79 
and pain management in this patient population outlined in literature; however, management 80 
with an approach of manual therapy and traditional strength and ROM exercises was 81 
recommended for the improvement of UE function.4,8 In the management of a survivor of breast 82 
cancer, the purpose of this case report was to describe the utilization of manual therapies, 83 
instrument assisted soft tissue mobilization (IASTM) and myofascial techniques (MFT) to 84 
address ROM, strength, and pain following surgery, chemotherapy, ET and RT treatments.  85 
  86 
         87 
Patient History and Systems Review    88 
   89 
Consent forms were signed by the patient for usage of information for participation in this 90 
case report. This 61-year-old Caucasian female was diagnosed in the spring of 2019 with a stage 91 
II ER+, PR+ and HER-2+ invasive ductal carcinoma of the right breast. A sentinel lymph node 92 
biopsy was performed in the following month, which was positive for macro metastases resulting 93 
in a right mastectomy and complete axillary dissection where an additional 22 nodes were 94 
removed. A simple mastectomy was then performed on the left prophylactically. Six cycles of 95 
adjuvant chemotherapy/immunotherapy were then introduced in the summer of 2019 (see 96 





Appendix 1). After chemotherapy concluded, external beam RT was delivered to both the 97 
anterior and lateral right chest wall and axilla for four and a half weeks in the winter of 2019.  98 
The referral to physical therapy (PT) in the spring of 2020 was for the diagnosis of 99 
malignant neoplasm in unspecified right breast with primary complaints of stabbing pain in her 100 
right shoulder, scapula and arm with significant shoulder tightness. She was a divorced single 101 
mother with an adult son who lived independently, working full-time as an office administrator 102 
and part-time (eight hours/week) as a dance and yoga instructor at a local wellness gym. She 103 
described nerve “zinging” along the posterior ribcage and a pulling sensation from her armpit to 104 
her hip on the right side which limited her from teaching classes. She had been receiving three-105 
times weekly infusions of chemotherapy and immunotherapy through a left subclavian venous 106 
access device (VAD), which remained in her chest until the summer of 2020. While she reported 107 
progress in survivorship, including gains in her strength, ability to dance, and participate in yoga, 108 
she was unsure how to address the continued pain and tightness. The primary problem in this 109 
case was decreased mobility in the right UE and trunk. She had a past medical history of 110 
osteoporosis which had not affected her daily life at that point. She had no other significant 111 
family history or comorbidities to report. Refer to Table 1 for information on the patient’s 112 
complete systems review.  113 
 The systems review revealed that the tissues of her right flank, breast and posterior 114 
shoulder girdle had mottled and puckered. Her surgical scars were closed and healed bilaterally, 115 
but her skin was taught, and mobilization of the right scapula caused movement and a pulling 116 
sensation into the right hip. Tissue extensibility in these areas was limited, with thickness noted 117 
in the right posterior shoulder and flank when compared bilaterally. Differential diagnoses for 118 
these findings were axillary cording, and/or myofascial post-surgical tightness. Tests and 119 
measures to be utilized were to assess strength, ROM, UE girth, tissue extensibility, and patient 120 





perception of limitation. This patient was an ideal candidate for this case report to emphasize the 121 
importance of manual therapy management of this condition in the outpatient setting, as well as 122 
the patient’s motivation for restoring ROM and strength to increase function in her right arm in 123 
order to return to her daily activity without restriction. 124 
 125 
Examination – Tests and Measures       126 
 127 
The limitations found in the history and systems review were further examined with tests 128 
and measures to determine specific impairments that were present (refer to Table 3). The Pain 129 
Disability Index (PDI), Quick Disability of the Shoulder, Arm and Hand (QuickDASH), 130 
Numeric Pain Rating Scale (NPRS), ROM testing, gross manual muscle testing (MMT), and arm 131 
circumferential girth measurements were utilized in the objective examination. At initial 132 
evaluation (IE), patient-reported outcome measures were completed (QuickDASH, PDI, NPRS) 133 
followed by assessment of vitals (heart rate, blood pressure, oxygen saturation), self-reported 134 
height in inches, and weight in pounds. The PT completed a patient history and the outcome 135 
measures of ROM, strength, palpation, and UE circumferential girth measurements (see Table 1). 136 
ROM assessments were conducted in a cervical to rostral manner into the UEs with a Jamar EZ-137 
Read standard goniometer (Performance Health, Warrenville, IL), performed in supine as 138 
outlined by Norkin et al.9 Muscle assessments of the shoulder, elbow and wrist were conducted 139 
bilaterally in sitting, utilizing UE techniques described by Kendall et al.10 Two UE 140 
circumferential measurements were taken bilaterally at midrange anatomical points to the patient 141 
morphological status with the shoulder in neutral and the elbow in full extension. These points 142 
were measured to be 7cm distally from the acromion process and 12cm distally from the 143 
olecranon process. A third measure at the hand was not completed. Circumferential 144 





measurements are valid with good clinical utility and were taken as baseline measurements for 145 
secondary lymphedema, an outcome measure recommended for use by Perdomo et al.11  146 
The purpose of the above outcome measures was to assess the patient’s functional ability 147 
and limitations restricting her daily activities. The patient reported outcome measures 148 
represented insight to the patient’s experience of the condition. Assessment of the QuickDASH 149 
allowed the clinician to analyze the amount of limitation the patient experienced specific to use 150 
of their UE in various tasks of everyday life (see Appendix 2). The QuickDASH is reported to 151 
have strong validity and reliability in orthopedic populations with shoulder pain and 152 
dysfunction.12 Although this outcome measure currently lacks literature psychometrically for the 153 
breast cancer population, the clinical utility remains strong in UE conditions and is 154 
recommended for use with breast cancer survivors by Miale et al.12 155 
The patient reported outcomes utilized for the measurement of pain in this case were the 156 
NPRS and the PDI. The PDI is utilized to measure the level of disability one experiences due to 157 
pain during seven various activities (see Appendix 3). The scoring represents the level of 158 
disability (a higher score indicates more disability due to pain restriction) that the individual 159 
experiences with daily tasks.13 The PDI is highly recommended for use by Harrington et al12 in 160 
the measurement of pain levels and disability. It is shown to have excellent construct validity and 161 
test-retest validity, although not specific to breast cancer populations.13 162 
The NPRS also is highly recommended for use in this population for measurement of 163 
pain in the experience of breast cancer by Harrington et al.13 This outcome measure has been 164 
validated for breast cancer pain as well as other musculoskeletal conditions.14 The NPRS has 165 
excellent reliability in many populations including cancer-related pain.14 166 
 167 
 168 





Clinical Impression: Evaluation, Diagnosis, Prognosis 169 
 170 
At IE, she experienced painful ROM, tightness, and loss of strength in the right arm that 171 
persisted since returning to her daily routines of dance and yoga. The problem list in this case 172 
included pain with use of the right shoulder, stiffness in the tissues of the right chest wall and 173 
breast, and loss of strength in the right UE. Although symptoms of cording were reported in her 174 
trunk, palpation of the axilla and antecubital fossa during shoulder abduction did not demonstrate 175 
signs of roping cords which is the most common presentation in evaluation of axillary web 176 
syndrome.7 Due to the elevated risk of lymphedema following ALND, ongoing monitoring must 177 
be considered in the plan of care (POC). Following examination, the initial impression was the 178 
loss of glenohumeral ROM was due to myofascial and tissue restrictions which deemed the 179 
patient an appropriate client for treatment. She was an ideal candidate for this case report to 180 
demonstrate the utilization of MFT due to UE pain and tissue restriction related to her cancer 181 
treatments. The medical diagnosis of this IE was ICD-10 code: C50.911 (malignant neoplasm of 182 
unspecified site of right female breast). The PT diagnosis was classified as ICD-10 codes L90.5 183 
(scar conditions and fibrosis of skin), and R53.1 (weakness).  184 
The prognosis for her rehabilitation was evaluated to be good. Positive prognostic factors 185 
included her history of an active lifestyle of dance and yoga routines maintained prior to and 186 
with therapy, as well as her determination to improve with therapy and maintain her health.15 187 
Treatments of MFR and soft tissue mobilization also show positive utility as an additional 188 
modality for treatment of UE limitation in breast cancer survivors,3,6,16 as well as in the Ascent 189 
Physical Therapy philosophy of clinical practice to increase tissue pliability along adhesions of 190 
scarring in UE conditions.17 No consultations or referrals were warranted at the time of IE to 191 
start the POC. Additional testing to be implemented were recertification notes with repeated 192 
outcome measures every four weeks. Visits at the time of IE were scheduled for 40-minute 193 





sessions twice a week for 12 weeks. The planned PT sessions consisted of treatments of 194 
therapeutic activities of: foam rolling activities using a 36” length, 6” width AmazonBasics 195 
Foam Roller (Amazon, Seattle, WA); therapeutic exercises including manual self-stretching; 196 
yoga; manual therapies such as soft tissue mobilizations; IASTM with Zabrina hot stones 197 
(Qincheng Liu, Minzhi, CN.); MFR; education of self-care strategies of lymphedema risk 198 
reduction; and a home exercise program instruction with self-massage techniques. Long- and 199 
short-term goals and timelines are outlined in Appendix 4. Re-certifications and evaluations of 200 
the POC with consultation with her referring physician were completed at every four-week 201 




Intervention and Plan of Care          206 
Communication, Coordination and Documentation 207 
 Communication was consistent between the patient, PT student, PT, and rehab aides 208 
regarding the POC and patient responsiveness to treatment. Progress notes at every four weeks 209 
were electronically signed and confirmed with her referring physician throughout the duration of 210 
care. The PT student coordinated with the PT on all aspects of care prior to the patient’s 211 
treatment sessions. The patient’s case was documented using WebPT (WebPT, Phoenix, AZ.) 212 
electronic medical record service. 213 
Patient Education    214 
 Education of findings in the IE was provided to the patient to ensure understanding of the 215 
present condition including treatment effects on ROM and strength. Consent to the POC was 216 
received from the patient and further education was also provided throughout her care on 217 
increased risk of lymphedema.  218 





 The patient was seen twice a week for 12 weeks in 40-minute durations. Visits were 219 
decreased to once weekly after eight weeks as she progressed and became independent with self-220 
management between sessions. There were three missed appointments throughout the duration of 221 
care due to pain and fatigue. A total of five progress notes were completed every four weeks 222 
until the most recent recertification was obtained in the fall of 2020. Treatments provided for the 223 
patient’s presentation were manual therapies, therapeutic exercises and a home exercise program 224 
(HEP) to improve right shoulder ROM, strength and pain management.4,8 The co-intervention 225 
provided in the duration of this treatment was the surgical removal of the VAD from her left 226 
subclavian after 10 weeks.  227 
 228 
Manual Therapy 229 
 During the IE, the tissues of the right pectoral, axillary, trunk and flank regions demonstrated 230 
observable tightness and discomfort with overhead motions. Upon palpation, the soft tissues 231 
were taught, potentially due to the late effects of surgical trauma and RT. Manual techniques 232 
were selected to address the loss of tissue pliability, and to decrease pain (See Table 2).3,4 233 
Although no research indicates the use of thermal IASTM for the treatment of UE limitation due 234 
to breast cancer treatments, it was utilized for patient comfort as introduction to manual 235 
therapies. Myofascial unwinding was selected as the clinical utility in a randomized control trial 236 
was demonstrated in breast cancer survivors to decrease pain and increase ROM of the neck and 237 
shoulder (refer to Appendix 5).20 Trigger point releases were completed in side-lying and held 238 
until tissue release with passive scapular mobilization to decrease nerve pain and sensitivity to 239 
overhead motions.8 MFR was performed in left side lying, prone, and supine with sustained 240 
holds utilizing pin and stretch techniques.5 Patient positioning during various manual therapies 241 
was selected based on presentation, chief complaint of the visit, and loss of tissue extensibility 242 





assessed by palpation. Initial sessions included 30 minutes of manual therapy with 10 minutes of 243 
HEP instruction. After three sessions, the patient demonstrated competence with her HEP and 244 
sessions were transitioned to full 40-minute manual sessions to maximize the patient’s benefit of 245 
treatment (see Table 3).  246 
Therapeutic Exercise 247 
 Throughout the POC, the patient continued a home yoga routine daily, which was 248 
encompassed into her home program for strengthening due to the adherence and approval from 249 
the therapist to continue. It has been shown that in those at risk for lymphedema post-ALND and 250 
RT, performance of yoga results in small gains of strength and ROM in the UE.21 Due to the 251 
patient’s motivation for continued exercise at home, manual therapy was the primary focus for in 252 
clinic treatments with the HEP continued independently.  253 
Home Exercise Program 254 
 The patient’s HEP was introduced in the third visit, designated to improve her UE and 255 
thoracic ROM. She utilized various yoga positions with thoracic mobilization and UE stretches 256 
with a foam roller parallel to the thoracic spine daily to increase thoracic mobility, UE ROM and 257 
tolerance for various overhead positions. The HEP also included manual lymph drainage to the 258 
right axilla and trunk that the patient completed independently at home for between-session 259 
management (see Appendix 6).  260 
 261 
TIMELINE 262 





OUTCOMES           268 
Over the duration of treatment, the patient was seen by the student PT for a total of 22 visits 269 





over 16 weeks. The care of the patient was then continued by the in-house therapist for 26 visits 270 
over the next 23 weeks. While the patient expressed reduction of pain with treatment sessions, 271 
she reported increased sensations of tightness with longer durations between visits. At visit 26, it 272 
was agreed to alter the POC to continue treatments in bi-monthly sessions for eight weeks to 273 
encourage further self-management between visits.  274 
Final measurements of outcome measures were assessed at visit 26. Her ROM was 275 
unchanged, however, perceived symptoms of pulling at terminal UE ranges had decreased. 276 
Circumferential girth measures were unchanged, presumably due to no presence of edema noted 277 
in the UE at the IE, and no new onset during the episode of care. Her strength in the right UE 278 
increased from 4/5 to 4+/5 at week four, but remained consistent from that time forward. 279 
Although no data was found to support a significant change in strength, she reported functional 280 
ability to continue teaching classes without pain or perceived weakness. This was represented in 281 
the patient-reported values of the PDI decreasing from 4/10 to 1/10. The QuickDASH score 282 
decreased from 27.27/100 to 11.36/100, indicating a change greater than the minimal clinically 283 
important difference of 10 in UE patient populations.22 She reported decreased pain from 2/10 284 
with movement to 1/10 experienced only at terminal ranges of overhead motions on the NPRS 285 
scale. See Table 3 for complete outcome measure data throughout the duration of care.  286 
Anticipated follow-up measures will include those of continued circumferential girth 287 
measures of the UE to monitor for the possibility of lymphedema onset, as well as continued 288 
measurements of UE ROM and soft tissue changes for continued sensations of tightness to 289 
monitor for axillary web syndrome.  The patient was last seen by her referring medical 290 
oncologist in the summer of 2020 during this POC with future follow-ups scheduled. She 291 
demonstrated physical and verbal self-efficacy with her HEP and stretching routines as well as 292 
manual self-techniques prescribed in the clinic, however she reported days between visits with 293 





the inability to complete her HEP due to fatigue and malaise. There were no adverse or 294 
unanticipated events related to her treatment. 295 
 296 
DISCUSSION          297 
This case report was intended to illustrate a multifocal approach of manual therapy and 298 
therapeutic exercise shown in the literature to increase ROM, strength, and manage pain in a 299 
breast cancer survivor post-surgery and adjuvant therapies4,6,8 At the time of discharge, the 300 
patient made minimal gains in right UE strength and tolerance for terminal overhead motions 301 
with decreased pain, which may be attributed to the elevated level of function the patient 302 
presented at baseline. Follow-up continued to be important as tightness and restriction persisted 303 
in her right UE, indicating bi-monthly visits prioritizing self-management for symptoms of 304 
potential axillary web syndrome.7 Outcomes may indicate the utility of manual treatments 305 
accompanied by therapeutic exercise in PT to manage limitations experienced in the treatment of 306 
a patient post-breast cancer treatment.  307 
The symptoms of axillary cording and the relation of systemic and local effects of 308 
adjuvant medical and radiation oncology following surgery should be considered clinically in 309 
this case. Although etiology is unclear, and pulling sensations at the hip with UE motion without 310 
palpable cords is not the most common presentation, these symptoms should be considered and 311 
addressed appropriately in the outpatient PT management of breast cancer survivors.3,7,25 PT 312 
interventions for UE pain and limitation may need to include distal treatments in the hip or trunk 313 
to prevent inactivity due to pain. Physiologically, the late effects of breast cancer treatments may 314 
cause pain, fatigue, and weight gain. As elevated body mass index has been shown to be the 315 
primary risk factor for lymphedema in those post-ALND, it should be addressed as well in PT 316 
care and patient education in this high-risk population.3,4,5,7,24,26,27 317 





Limitations in this case include lack of evidence indicating the safe use of thermal 318 
IASTM in this population, as this has the potential to increase the risk of lymphedema post-319 
ALND and on radiated tissue. Another limitation was that the degree of fatigue and malaise was 320 
not measured, even though it impacted HEP adherence. The strength in this case was the 321 
extremely motivated and otherwise healthy patient who continued to be as active as possible 322 
throughout her care, as she utilized yoga as a form of strengthening and HEP, which enabled 323 
manual therapy to be the focus for PT sessions in the clinic.  324 
Outpatient PTs will continue to be utilized in the management breast cancer survivors as 325 
medical innovations continue to increase the population of those potentially experiencing UE 326 
limitation in ROM, strength, and mobility. The treatment of survivors should be considered more 327 
specifically to fatigue, pain, lymphedema and axillary cording monitoring, as well as 328 
cardiovascular and bone health. This results in the need for outpatient PTs to dedicate time 329 
through continuing education for meaningful lifelong function and risk management in this 330 
population. Future research in this area of expertise should focus on treatment parameters for 331 
both therapeutic exercises to promote UE function, and manual therapy to reduce the risk of 332 
lymphedema and axillary cording in those post-ALND, chemotherapy, ET and RT treatments. 333 
The understanding and implementation of this may help patients experience a more effective 334 
reduction of post-oncologic symptoms, increased UE functioning, and quality assistance in 335 
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TABLES and FIGURES Table 1: Systems Review 434 
Cardiovascular/Pulmonary  Not impaired.  
Heart rate: 75 Beats per minute, radial pulse 
Blood Pressure: 120/95mmHg in upper arm in sitting 
Oxygen Saturation: 97% on room air 
Musculoskeletal Gross Cervical ROM: No impairments 
Gross Shoulder ROM: Impaired on right, painful at end ranges  
Gross Elbow ROM: No impairment 
Gross Wrist ROM: No impairment 
Height: 62 inches 
Weight: 115 pounds 
Neuromuscular Impaired: Numbness and tingling periodically into the lower extremities, as 
well as into her 3rd, 4th, and 5th digits on her right hand. Nerve pain 
experienced into her posterior right flank.  
Integumentary Bilateral mastectomy scarring. Scars are clean, closed, and fully healed. No 
other radiation therapy changes noted. No edema or upper extremity 
circumferential changes noted. Mottling and puckering of right flank, breast 
and posterior shoulder girdle tissues.  
Communication No impairments. 
Affect, Cognition, 
Language, Learning Style 
Affect: Quiet, friendly 
Language: English  
Cognition: No impairments 
Learning Style: Tactile, or Visual learning 
Abbreviations: mmHg = millimeters of Mercury  435 
 436 
Table 2: Manual Therapy Techniques  437 
Manual 
Therapy 
Phase 1:  










Mobility, Education Tissue Extensibility, Pliability 
and Scapular Mobility 
Self-Management and ROM 
Maintenance  
IASTM – hot 
stone 
Trunk, chest, axilla to 
UE 
Trunk, chest, axilla to UE Trunk, lateral chest wall, axilla to 
UE, peri-scapular area 
MFR Lateral R trunk, chest 
scapula, to hip 
Lateral R trunk, scapula, to hip R lateral flank, hip, abdominal 
wall, anterior R pectorals, inferior 




distraction to hip on R 
RUE PROM, distraction to hip 
on R 
 
TrP Releases Subscapular release Inferior and medial boarder of 
scapula 
 
STM Trunk, chest, axilla to 
UE 
Trunk, chest, axilla to UE Axilla to anteriolateral flank, R 
abdominal and hip 
Scapular 
Mobilization 
 Protraction and elevation  
Abbreviations: Tx: treatment. IASTM: instrument assisted soft tissue mobilization. MFR: myofascial release. MF: myofascial. 438 
TrP: trigger point. STM: soft tissue mobilization. UE: upper extremity. RUE: right upper extremity. PROM: passive range of 439 
motion: R: right. ABD: abduction. Lat: lateral 440 
 441 




















Table 3: Test and Measures Timeline of Outcomes   452 








3/10 3/10 3/10 1/10 
QuickDASH 27.27/100.  




13.64/100 9.09/100 11.36/100 11.36/100 
Numeric Pain 
Rating Scale 
2/10, a “tight” pain experienced with 
activity only. 
10 indicates maximum level of pain 
experienced.  
2/10, a “tight” 
pain experienced 
with activity only 
 
2/10 2/10 1/10 1/10 
Girth 
Measurement  
R Upper Arm: 25.5cm. Measured 7cm 
distally from acromion 
R Lower Arm: 18cm. Measured 12cm 
distally from olecranon 
L Upper Arm: 26 cm. Measured 7cm 
distally from acromion 
L Lower Arm: 18cm. Measured 12cm 











































WNL all UE motions BL, pain in axilla 
to R flank and hip experienced in mid- 
ranges/motions of shoulder flexion and 
abduction 
WNL, pulling in 
back of shoulder 
R flank and hip 
with over- head 
RUE motion 
WNL, continued 
tightness in R 
scapula, flank 
WNL, end range 








WNL, slight pull 





                                             R         L 
Flexion:                              4/5         4/5 
Abduction:                         4/5         4/5 
Internal Rotation:               4/5         4/5 
External Rotation:              4/5         4/5 
R               L 
4+/5        4+/5 
4+/5        4+/5 
4+/5        4+/5 
4+/5        4+/5 
R            L 
4+/5      4+/5 
4+/5      4+/5 
4+/5      4+/5 
4+/5      4+/5 
R            L 
4+/5      4+/5 
4+/5      4+/5 
4+/5      4+/5 
4+/5      4+/5 
R            L 
4+/5      4+/5 
4+/5      4+/5 
4+/5      4+/5 
4+/5      4+/5 
R            L 
4+/5      4+/5 
4+/5      4+/5 
4+/5      4+/5 
4+/5      4+/5 
Elbow 
Strength  
Flexion:                              4/5         4/5  
Extension:                          4/5         4/5 
4+/5        4+/5  
4+/5        4+/5 
4+/5      4+/5  
4+/5      4+/5 
4+/5      4+/5  
4+/5      4+/5 
4+/5      4+/5  
4+/5      4+/5 
4+/5      4+/5  
4+/5      4+/5 
Wrist Strength  Flexion:                              4/5         4/5  
Extension:                          4/5         4/5  
4+/5        4+/5  
4+/5        4+/5  
4+/5      4+/5  
4+/5      4+/5 
4+/5      4+/5  
4+/5      4+/5 
4+/5      4+/5  
4+/5      4+/5 
4+/5      4+/5  
4+/5      4+/5 
Abbreviations: WNL–within normal limits. Cm=centimeters. R=right. L=left. UE=upper extremity. BL=bilaterally. 4/5 indicating ability to hold contraction against gravity with 453 
minimal resistance. 4+/5 indicating ability to hold contraction against gravity with moderate resistance.454 






APPENDICES Appendix 1: Medication List  456 
Medication Indication 
Anastrazole Endocrine Therapy 
Calcium Osteoporosis 
Carboplatin Chemotherapy  
Cetrizine Hydrochloride Allergies  
Fozomax Osteoporosis  
Herceptin Immunotherapy  
Multivitamin Dietary Supplement 
Pegfilgrastim Bone Marrow Stimulant  
Perjeta Immunotherapy 
Taxotere Chemotherapy  










Appendix 2: QuickDASH18 466 








Appendix 3: Pain Disability Index19 470 








Appendix 4: Short and Long-Term Goals 474 





Length Status Goal 
Short-term: 
4 weeks 
Goal Met  
 
Independent with HEP. 
Client will be independent with home exercise program of a 
self-thoracic mobilization and foam rolling program for self-





Minimal complaints of 
stiffness at end range. 
Client will no longer have reported stiffness at end range of 
motion overhead when compared bilaterally for improved 





Trigger points have 
resolved. 
Client will present with resolved trigger points in the right 





No longer experiencing 
nerve pain. 
Client will report no nerve pain along the right ribcage for 







to patient tolerance.  
Client will demonstrate strength approaching normal as 









Client will present with increased tissue mobility in right 
shoulder, flank and scapula as compared bilaterally for 
participation in overhead activity. 
 475 
Appendix 5: Myofascial Unwinding Technique20 476 
The patient relaxes, while the therapist applies 477 
traction to the upper extremity in various 478 
positions of flexion, abduction with combined 479 
internal and external rotations. Held for 30 to 480 









Appendix 6: Home Exercise Program  485 
6a: Standing Tree Hug        486 





6b: Sitting Tree Hug 492 





6c: Pec Minor Stretch on Foam Roll 498 
2x30 second hold 499 
 500 
6d: Foam Roll Snow Angels 501 
2x30 second hold in overhead position 502 
 503 
 504 
6e: Foam Roll Pec Stretch 1  505 









6f: Foam Roll Pec Stretch 2 510 




6g: Core Claps on Foam Roll 515 





Physical Therapist instructed patient to incorporate above stretches into her daily yoga routine. 521 

































































Day 0  
 
 














Patient was a 61-year-old female with a past medical history 
of right ER+, PR+ and HER2+ invasive ductal carcinoma 
and osteoporosis  
Patient continued therapy 2x/month for maintenance of 
ROM during transition to independent management 
Initial diagnosis of stage II invasive ductal carcinoma 
of the right breast 
Positive right sentinel lymph node biopsy leading to 
complete axillary node dissection was performed. 
Prophylactic mastectomy of left breast. 
Adjuvant chemotherapy and radiation initiated  
 
Onset of symptoms of right UE restriction, tightness, 
and pain with daily activities and yoga   
Initial Evaluation in Physical Therapy Clinic 
Interventions focused on patient education, 
addressing pain and ROM deficits 
Interventions focused on tissue extensibility, scapular 
mobility and strength 
Interventions focused on self-management, ROM and 
strength maintenance 





CARE Checklist 562 
 563 
     564 
CARE Content Area Page 
1. Title – The area of focus and “case report” should appear in the title 1 
2. Key Words – Two to five key words that identify topics in this case report 1 
3. Abstract – (structure or unstructured) 
a. Introduction – What is unique and why is it important? 
b. The patient’s main concerns and important clinical findings. 
c. The main diagnoses, interventions, and outcomes. 




4. Introduction – Briefly summarize why this case is unique with medical literature 
references. 
3-4 
5. Patient Information 
a. De-identified demographic and other patient information. 
b. Main concerns and symptoms of the patient. 
c. Medical, family, and psychosocial history including genetic information. 
d. Relevant past interventions and their outcomes. 
4-5 
6. Clinical Findings – Relevant physical examination (PE) and other clinical findings 6-7 
7. Timeline – Relevant data from this episode of care organized as a timeline (figure 
or table). 
27 
8. Diagnostic Assessment 
a. Diagnostic methods (PE, laboratory testing, imaging, surveys). 
b. Diagnostic challenges. 
c. Diagnostic reasoning including differential diagnosis. 
d. Prognostic characteristics when applicable. 
8-9 
9. Therapeutic Intervention 
a. Types of intervention (pharmacologic, surgical, preventive). 
b. Administration of intervention (dosage, strength, duration). 
c. Changes in the interventions with explanations. 
9-11 
10. Follow-up and Outcomes 
a. Clinician and patient-assessed outcomes when appropriate. 
b. Important follow-up diagnostic and other test results. 
c. Intervention adherence and tolerability (how was this assessed)? 
d. Adverse and unanticipated events. 
12-13 
11. Discussion 
a. Strengths and limitations in your approach to this case. 
b. Discussion of the relevant medical literature. 
c. The rationale for your conclusions. 
d. The primary “take-away” lessons from this case report. 
13-14 
12. Patient Perspective – The patient can share their perspective on their case. 5 
13. Informed Consent – The patient should give informed consent. 4 
